The Medical News

The Medical News

Research review discusses anti-cancer properties of turmeric The team's findings on using temperature monitoring to detect graft-versus-host disease appear in the journal Blood Advances . The research was led by fellows Kuang He, Ph.D., and Hideaki Fujiwara, M.D., Ph.D., and involved a close collaboration between the faculty research groups of Tewari, Zhenke Wu, Ph.D. of the U-M School of Public Health, and Sung Won Choi, M.D. and Pavan Reddy, M.D., of the Medical School. Bone marrow transplants are a common treatment for cancers including leukemia, lymphoma and myeloma. GVHD occurs when the immune system from the transplant donor sees the recipient's cells as invaders and attacks them. Up to half of transplant recipients will develop acute GVHD, of which one third will be severe cases, one recent study found. Biomarkers for graft-versus-host disease have been developed, but predicting GVHD's onset in individual patients remains imprecise, notes Tewari, a professor of internal medicine at the U-M Medical School, and of biomedical engineering, a joint department of the Medical School and College of Engineering. The research team used machine learning to detect subtle patterns in the temperature data before obvious trends would be apparent to human observers. They analyzed hourly temperature readings and, since mice are nocturnal, day-night temperature differences. Both measurements were able to distinguish differences among the mice prone to GVHD within the first four to six days after transplantation. To extend the research to humans, further study is needed evaluate temperature patterns in human patients, and to better understand potential complicating factors such as variations in room temperature, the presence of infection or the use of medications that can alter body temperature. Source: Michigan Medicine - University of Michigan Journal reference: He, K., et al. (2019) Computational analysis of continuous body temperature provides early discrimination of graft-versus-host disease in mice. Blood Advances . doi.org/10.1182/bloodadvances.2019000613 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More